The changes induced by cyclophosphamide in intestinal barrier and microflora in mice

scientific article

The changes induced by cyclophosphamide in intestinal barrier and microflora in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJPHAR.2013.06.006
P698PubMed publication ID23791611

P2093author name stringJin Yang
Xiao-dan Wang
Jie-ming Qu
Kai-xiong Liu
P433issue1-3
P407language of work or nameEnglishQ1860
P304page(s)120-124
P577publication date2013-06-18
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleThe changes induced by cyclophosphamide in intestinal barrier and microflora in mice
P478volume714

Reverse relations

cites work (P2860)
Q55400532A Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides.
Q48005842C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1, occludin and claudin-4 expression
Q62802243Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment
Q97067045Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model
Q28076294Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
Q56036313Dietary fucoidan of Acaudina molpadioides and its enzymatically degraded fragments could prevent intestinal mucositis induced by chemotherapy in mice
Q41490537Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury
Q35226638Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy.
Q47722011Effects of polysaccharides from purple sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide treated mice.
Q90248075Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
Q89429091Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities
Q36088090Immunosuppression, peripheral inflammation and invasive infection from endogenous gut microbiota activate retinal microglia in mouse models.
Q64118992KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice
Q35932477Lactobacillus plantarum NCU116 attenuates cyclophosphamide-induced intestinal mucosal injury, metabolism and intestinal microbiota disorders in mice.
Q65001698Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.
Q92258393Myricetin Abrogates Cisplatin-Induced Oxidative Stress, Inflammatory Response, and Goblet Cell Disintegration in Colon of Wistar Rats
Q55040688Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
Q57099887The Polysaccharides from Modulates the Immunity and Intestinal Microbiota of Cyclophosphamide-Treated Immunosuppressed Mice
Q91272530The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model
Q49276632The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
Q31144277The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
Q37707075The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice
Q35346303The role of the microbiota in inflammation, carcinogenesis, and cancer therapy
Q41545568The squid ink polysaccharides protect tight junctions and adherens junctions from chemotherapeutic injury in the small intestinal epithelium of mice

Search more.